Stockscreener 앱 받기
309.89
1.58%
4.83
시간 외 거래:
309.94
0.05
+0.02%
전일 마감가:
$305.06
열려 있는:
$306.9
하루 거래량:
833.38K
Relative Volume:
0.47
시가총액:
$60.29B
수익:
$328.68B
순이익/손실:
$2.55B
주가수익비율:
23.77
EPS:
13.0349
순현금흐름:
$1.56B
1주 성능:
+0.65%
1개월 성능:
+8.94%
6개월 성능:
-12.33%
1년 성능:
+6.69%
1일 변동 폭
$304.25
$310.30
1주일 범위
$298.43
$310.30
52주 변동 폭
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
명칭
Cencora Inc
전화
610-727-7000
주소
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
309.89 | 60.29B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
840.90 | 98.45B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
228.03 | 53.41B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
85.47 | 9.74B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.51 | 1.29B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-06-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 재개 | Mizuho | Outperform |
| 2024-09-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2023-01-31 | 재개 | Evercore ISI | Outperform |
| 2022-10-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-07-11 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-05-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-04-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2021-03-12 | 재개 | Evercore ISI | In-line |
| 2021-02-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-02-02 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-01-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-01-06 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 개시 | Mizuho | Neutral |
| 2020-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 개시 | Barclays | Underweight |
| 2020-06-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 재개 | Credit Suisse | Outperform |
| 2020-04-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-03-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-11 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-07-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 개시 | Guggenheim | Buy |
| 2019-04-10 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-02-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-10-26 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 개시 | Berenberg | Buy |
| 2018-07-17 | 재개 | Stifel | Hold |
| 2018-04-09 | 개시 | MoffettNathanson | Buy |
| 2018-03-12 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 개시 | JP Morgan | Neutral |
| 2017-09-22 | 개시 | William Blair | Outperform |
모두보기
Cencora Inc 주식(COR)의 최신 뉴스
Cencora Inc (COR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cencora Inc (COR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
COR|Cencora Inc|Price:309.890|Chg%:+4.765 - TradingKey
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora (COR) Stock Could Be 39% Below Fair Value - simplywall.st
A4EQAC Bond Risk Profile - TradingView
Here's Why You Should Add Cencora Stock to Your Portfolio Now - Yahoo Finance UK
Zacks.com featured highlights include AIM ImmunoTech, Hasbro, Fox, Cencora and Intuitive Surgical - Yahoo Finance
Cencora stock holds steady as investors await fresh numbers - AD HOC NEWS
Cencora stock trades steady as specialty distribution scale and recent earnings shape investor view - AD HOC NEWS
COR stock consolidates after strong fiscal 2025 results and guidance update - Ad-hoc-news.de
Cencora: Specialty Infrastructure Is Rewriting The Distributor Model (NYSE:COR) - Seeking Alpha
Cencora earnings preview: What to expect - MSN
ABC5953643 Bond Risk Profile - TradingView
COR|Cencora Inc|Price:305.030|Chg%:+4.450 - TradingKey
Cencora stock trades steadily as pharmaceuticals distributor highlights rising revenue and earnings - Ad-hoc-news.de
Cencora, Inc. Stock 12‑Month Price Target Raised to $354.58, Implies 17% Upside - TradingView
ETFs Investing in Cencora, Inc. Stocks - TradingView
Cencora stock trades near record levels as earnings and guidance underpin healthcare distribution gr - Ad-hoc-news.de
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Cencora stock holds firm as revenue and profit trends stay in focus - Ad-hoc-news.de
US3073EBC8 Bond Risk Profile - TradingView
Cencora stock trades near record levels as specialty distribution growth supports earnings - AD HOC NEWS
Steve Collis: Pharmaceutical Distribution Leader and Former Chairman, President, and CEO of Cencora - BBN Times
Cencora stock holds after fiscal 2026 growth update - ad-hoc-news.de
Cencora stock trades steadily as recent earnings highlight solid revenue growth - ad-hoc-news.de
XS3071246378 Bond Risk Profile - TradingView
XS3071246378 Bond Coupon Profile — Rate & Payments - TradingView
ABC6310083 Bond Coupon Profile — Rate & Payments - TradingView
XS3071246378 Bond Profile — Key Metrics - TradingView
Cencora stock trades steadily as specialty distribution growth supports earnings - Ad-hoc-news.de
Fund Update: 235,570 CENCORA (COR) shares added to FORT WASHINGTON INVESTMENT ADVISORS INC |OH| portfolio - Quiver Quantitative
Cencora Earnings Preview: What to Expect - inkl
A1ZW87 Bond Coupon Profile — Rate & Payments - TradingView
Lobbying Update: $60,000 of CENCORA INC. lobbying was just disclosed - Quiver Quantitative
ABC6310086 Bond Profile — Key Metrics - TradingView
Is Cencora Inc (COR) Overvalued After 3.9% Rally? GF Value Says - GuruFocus
Cencora stock reflects steady healthcare distribution role as investors track U.S. drug spending tre - ad-hoc-news.de
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
ABC5953320 Bond Risk Profile - TradingView
ABC4571978 Bond Coupon Profile — Rate & Payments - TradingView
How Cencora’s Revenue Miss Amid Growth Will Impact Cencora (COR) Investors - simplywall.st
ABC5953320 Bond Profile — Key Metrics - TradingView
ABC6310084 Bond Coupon Profile — Rate & Payments - TradingView
ABGB Bond Profile — Key Metrics - TradingView
ABC6310085 Bond Coupon Profile — Rate & Payments - TradingView
ABC4571978 Bond Profile — Key Metrics - TradingView
Cencora stock reflects steady growth as healthcare distribution evolves - Ad Hoc News
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cencora (COR) Following Soft Earnings Is The Stock Starting To Look Undervalued - simplywall.st
ABC4987224 Bond Risk Profile - TradingView
Cencora Inc (COR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
자본화:
|
볼륨(24시간):